# InMed Pharmaceuticals Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:a2572fa4-f295-4e72-82fe-483a124bcdf0 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/inmed-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 20 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-21T04:47:21.26074+00:00 | | Last reviewed | 2026-10-21T04:47:21.26074+00:00 | ## Identity - Legal name: InMed Pharmaceuticals Inc. - Display name: InMed Pharmaceuticals Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-22T00:18:51.252905+00:00 | | Completeness | 0.409 | | Record Quality | 0.832 | | Directors | 5 | | Committees | 5 | | Governance events | 11 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Andrew Hull: Director. Status: current. Independent: true. Since: 2016-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance · Chair (member); Compensation (member); Nominating and Governance (chair). claim_id=alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:5 - Eric A. Adams: Director. Status: current. Independent: false. Since: 2016-01-01. claim_id=alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:6 - John Bathery: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:7 - Neil Klompas: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:8 - Nicole Lemerond: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Audit (member); Audit; Compensation · Chair; Nominating and Governance (member); Compensation (chair); Nominating and Governance (member). claim_id=alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:9 ## Committees - Audit (audit). Chair: NOT_PUBLISHED. Members: Andrew Hull (member, current); Nicole Lemerond (member, current). committee_id=alpha:committee:inmed-pharmaceuticals-inc:audit - Audit; Compensation · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Nicole Lemerond (member, current). committee_id=alpha:committee:inmed-pharmaceuticals-inc:audit-compensation-chair-nominating-and-governance - Audit; Compensation; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Andrew Hull (member, current). committee_id=alpha:committee:inmed-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair - Compensation (compensation). Chair: Nicole Lemerond. Members: Nicole Lemerond (chair, current); Andrew Hull (member, current). committee_id=alpha:committee:inmed-pharmaceuticals-inc:compensation - Nominating and Governance (nominating_governance). Chair: Andrew Hull. Members: Andrew Hull (chair, current); Nicole Lemerond (member, current). committee_id=alpha:committee:inmed-pharmaceuticals-inc:nominating-and-governance ## Executive leadership - Eric A. Adams: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:10 - Netta Jagpal: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:11 ## Governance events - CEO_CHANGED: Eric A. Adams executive of InMed Pharmaceuticals Inc., effective 2025-09-23. Effective: 2025-09-23. Detected: 2026-10-21T04:47:21.26074+00:00. event_id=alpha:event:transition:1pgb09y1hh1zoy - CFO_CHANGED: Netta Jagpal executive of InMed Pharmaceuticals Inc., effective 2025-09-23. Effective: 2025-09-23. Detected: 2026-10-21T04:47:21.26074+00:00. event_id=alpha:event:transition:1fjgcw3qgxpkn - DIRECTOR_APPOINTED: John Bathery seat on InMed Pharmaceuticals Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-21T04:47:21.26074+00:00. event_id=alpha:event:transition:18c6i0p1hyjhdb - DIRECTOR_APPOINTED: Neil Klompas seat on InMed Pharmaceuticals Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-21T04:47:21.26074+00:00. event_id=alpha:event:transition:8b60nok4ss98 - DIRECTOR_APPOINTED: Nicole Lemerond seat on InMed Pharmaceuticals Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-21T04:47:21.26074+00:00. event_id=alpha:event:transition:qpjuqc80v986 - COMMITTEE_CREATED: Audit; Compensation · Chair; Nominating and Governance committee of InMed Pharmaceuticals Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-21T04:47:21.26074+00:00. event_id=alpha:event:transition:1tx4rww1896ona - COMMITTEE_MEMBER_ADDED: Nicole Lemerond member of Audit; Compensation · Chair; Nominating and Governance, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-21T04:47:21.26074+00:00. event_id=alpha:event:transition:1dhp4hg1164m2g - DIRECTOR_APPOINTED: Andrew Hull seat on InMed Pharmaceuticals Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-21T04:47:21.26074+00:00. event_id=alpha:event:transition:11rmy2vpl1jd9 - DIRECTOR_APPOINTED: Eric A. Adams seat on InMed Pharmaceuticals Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-21T04:47:21.26074+00:00. event_id=alpha:event:transition:1oh5j901w90xxy - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance · Chair committee of InMed Pharmaceuticals Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-21T04:47:21.26074+00:00. event_id=alpha:event:transition:l7s7p31ovoc85 - COMMITTEE_MEMBER_ADDED: Andrew Hull member of Audit; Compensation; Nominating and Governance · Chair, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-21T04:47:21.26074+00:00. event_id=alpha:event:transition:1r5qjvj1vbrcjv ## Scoped resources - `alpha://company/inmed-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record - `alpha://company/inmed-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/inmed-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/inmed-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=board - `alpha://company/inmed-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/inmed-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/inmed-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/inmed-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/inmed-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/inmed-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/inmed-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/inmed-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/inmed-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/inmed-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/inmed-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/inmed-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/inmed-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/inmed-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/inmed-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/inmed-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=events - `alpha://company/inmed-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/inmed-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/inmed-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:13: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:andrew-hull","name":"Andrew Hull"},"source_id":"board_seats"}` - Claim alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:nicole-lemerond","name":"Nicole Lemerond"},"source_id":"board_seats"}` ## Leadership - Andrew Hull: Director, Audit; Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:5. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e. - Eric A. Adams: Director. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:6. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e. - John Bathery: Director. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:7. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e. - Neil Klompas: Director. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:8. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e. - Nicole Lemerond: Director, Audit; Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:9. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e. - Eric A. Adams: President, Chief Executive Officer and Director. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:10. Valid from: 2025-09-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:67b5cdadce1a068f02322c3bf0fbc1dfa22a798b11fa670f243ee1e981ea7b54. - Netta Jagpal: Chief Financial Officer. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:leadership_role:11. Valid from: 2025-09-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e0e90afaef68572d3c27f13be57966a41f4970916e9e6cacbc6af1018a380bc2. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair not stated; Members Andrew Hull; Nicole Lemerond. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80. - Compensation: Chair Nicole Lemerond; Members Nicole Lemerond (Chair); Andrew Hull. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80. - Nominating and Governance: Chair Andrew Hull; Members Andrew Hull (Chair); Nicole Lemerond. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - InMed Pharmaceuticals Inc.. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e5df6eb1cae14bee51744d288732a20006a8b73aba9be32d7a1f8ee9b1f1de6b. ## Entity Status - Public listing published. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e5df6eb1cae14bee51744d288732a20006a8b73aba9be32d7a1f8ee9b1f1de6b. ## Published Fact - US. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e5df6eb1cae14bee51744d288732a20006a8b73aba9be32d7a1f8ee9b1f1de6b. ## Committee Appointment - Andrew Hull: member, Audit. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80. - Nicole Lemerond: member, Audit. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80. - Nicole Lemerond: chair, Compensation. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80. - Andrew Hull: member, Compensation. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80. - Andrew Hull: chair, Nominating and Governance. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80. - Nicole Lemerond: member, Nominating and Governance. Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80. ## Security Listing - INM (NASDAQ). Claim: alpha:claim:company:a2572fa4-f295-4e72-82fe-483a124bcdf0:security_listing:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e5df6eb1cae14bee51744d288732a20006a8b73aba9be32d7a1f8ee9b1f1de6b. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:e5df6eb1cae14bee51744d288732a20006a8b73aba9be32d7a1f8ee9b1f1de6b: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc). - alpha:projection-evidence:document:d55657e2e1a85a098818eefcb09ca1c0203aefe37c594136198ef89ce00d144e: [InMed Pharmaceuticals Inc. DEF 14A 2025-11-03](https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm). - alpha:projection-evidence:document:67b5cdadce1a068f02322c3bf0fbc1dfa22a798b11fa670f243ee1e981ea7b54: [INM 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1728328/000121390025090210/ea0253959-10k_inmed.htm). - alpha:projection-evidence:document:e0e90afaef68572d3c27f13be57966a41f4970916e9e6cacbc6af1018a380bc2: [INM 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1728328/000121390025090210/ea0253959-10k_inmed.htm). - alpha:projection-evidence:ebf7b46941955283b019653e911fdb1bbfbc34681452ef5a323a9adbd2f08e80: [Audit](https://www.sec.gov/Archives/edgar/data/1728328/000121390025104914/ea0262858-def14a_inmed.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/inmed-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/inmed-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/inmed-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/inmed-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-22T00:18:51.041471+00:00; recorded 2026-10-22T00:18:51.041471+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.